Role of endoscopic ultrasonography in the staging of esophageal cancer: A review

Current Opinion in Gastroenterology

Volumn 19, Issue 5, 2003, Pages 474-476

  Das, Ananya ^a   Chak, Amitabh ^a,b  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

Cancer staging; Endoscopic ultrasonography; Esophageal cancer

Indexed keywords

ACCURACY; ADJUVANT THERAPY; ASPIRATION BIOPSY; CANCER STAGING; CANCER SURVIVAL; COMPUTER ASSISTED TOMOGRAPHY; COST EFFECTIVENESS ANALYSIS; ENDOSCOPIC ECHOGRAPHY; ESOPHAGUS CANCER; EVALUATION; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MEASUREMENT; PREDICTION; RELIABILITY; REVIEW;

EID: 0042887506     PISSN: 02671379     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001574-200309000-00007     Document Type: Review

References (13)

1. Parmar KS, Zwischenberger JB, Reeves AL, Waxman I, Clinical impact of endoscopic ultrasound-guided fine needle aspiration of celiac axis lymph nodes (M1 a disease) in esophageal cancer. Ann Thorac Surg 2002, 73:916-920; 920-921.
2. Van Dam J, Rice TW, Catalano MF, et al.: High-grade malignant stricture is predictive of esophageal tumor stage: risks of endosonographic evaluation. Cancer 1993, 71:2910-2917.
3. Das A, Mourad W, Lightdale CJ, et al.: An international survey of the clinical practice of endoscopic ultrasonography (EVS) [abstract] Gastrointest Endosc 2003, 57:250.
4. Romagnuolo J, Scott J, Hawes RH, et al.: Helical CT versus EUS with fine needle aspiration for celiac nodal assessment in patients with esophageal cancer. Gastrointest Endosc 2002, 55:648-654. This study evaluated the performance of helical CT for evaluating T stage and celiac lymph nodes in patients with esophageal cancer with EUS-guided FNA as the reference standard.
5. Refaely Y, Krasna MJ: Multimodality therapy for esophageal cancer. Surg Clin North Am 2002, 82:729-746.
6. Mallery S, DeCamp M, Bueno R, et al.: Pretreatment staging by endoscopic ultrasonography does not predict response to neoadjuvant chemo-radiation in patients with esophageal carcinoma. Cancer 1999, 86:764-769.
7. Chak A, Canto MI, Cooper GS, et al.: Endosonographic assessment of multimodality therapy predicts survival of esophageal carcinoma patients. Cancer 2000, 88:1788-1795.
8. Willis J, Cooper GS, Isenberg G, et al.: Correlation of EUS measurement with pathologic assessment of neoadjuvant therapy response in esophageal carcinoma. Gastrointest Endosc 2002, 55:655-661. This study attempted to correlate the EUS measurement of tumor cross-sectional area after neoadjuvant therapy with histologic assessment of tumor regression. The findings of this study confirm that EUS measurement of reduction of tumor cross-sectional area is a good marker of response to chemo-radiotherapy.
9. Vazquez-Sequeiros E, Wiersema MJ: High-frequency US catheter-based staging of early esophageal tumors. Gastrointest Endosc 2002, 55:95-99.
10. Sumiyama K, Suzuki N, Kakutani H, et al.: A novel 3-dimensional EUS technique for real-time visualization of the volume data reconstruction process. Gastrointest Endosc 2002, 55:723-728. This report represent significant improvement in the technique of three-dimensional imaging by EUS and may be useful for improving the accuracy of assessment of response after chemo-radiotherapy.
11. Shumaker DA, de Garmo P, Faigel DO: Potential impact of preoperative EUS on esophageal cancer management and cost. Gastrointest Endosc 2002, 56:391-396. This study used a large national endoscopic database to evaluate the impact of EUS on the cost of the management of esophageal cancer.
12. Harewood GC, Wiersema MJ: A cost analysis of endoscopic ultrasound in the evaluation of esophageal cancer. Am J Gastroenterol 2002, 97:452-458.
13. Wallace MB, Nietert PJ, Earle C, et al.: An analysis of multiple staging management strategies for carcinoma of the esophagus: computed tomography, endoscopic ultrasound, positron emission tomography, and thoracoscopy/laparoscopy. Ann Thorac Surg 2002, 74:1026-1032. This decision analysis evaluated different strategies for the initial staging of esophageal cancer and supports the central role of EUS with FNA for staging of esophageal cancer in combination with other imaging modalities.